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Abstract
High confidence methods are needed for determining the glycosylation profiles 
of complex biological samples as well as recombinant therapeutic proteins. A com-
mon glycan analysis workflow involves liberation of N-glycans from glycoproteins 
with PNGase F or O-glycans by hydrazinolysis prior to their analysis. This method 
is limited in that it does not permit determination of glycan attachment sites. 
Alternative proteomics-based workflows are emerging that utilize site-specific 
proteolysis to generate peptide mixtures followed by selective enrichment strategies 
to isolate glycopeptides. Methods designed for the analysis of complex samples can 
yield a comprehensive snapshot of individual glycans species, the site of attachment 
of each individual glycan and the identity of the respective protein in many cases. 
This chapter will highlight advancements in enzymes that digest glycoproteins into 
distinct fragments and new strategies to enrich specific glycopeptides.
Keywords: glycoproteomics, glycopeptide enrichment, lectin, Fbs1, BGL, 
O-glycoprotease, alpha-lytic protease
1. Introduction
Protein glycosylation is a post-translational carbohydrate (‘glycan’) modification 
of eukaryotic proteins that may affect their folding, stability, localization and bio-
logical function. Glycan profiles differ from cell type to cell type and are known to 
be altered in carcinogenesis [1, 2], inflammation [3], and Alzheimer’s disease [4] etc. 
Importantly, circulating plasma proteins may serve as biomarkers as altered glyco-
sylation profiles may signal specific types of disease. Glycosylation may be assessed 
on a global level by isolating total protein from tissue, cells or serum followed by 
liberation of glycans and analysis by reliable methods such as ultra performance 
liquid chromatography (UPLC) coupled to mass spectrometry (MS). Profiling liber-
ated glycans is useful in some cases, but site of attachment (glycosite) and the glycan 
structure at each glycosite is more valuable. This “total picture” is attainable when 
performing liquid chromatography (LC) with tandem mass spectrometry (LC–MS/
MS) at the glycopeptide level. Furthermore, it is critically important to be able to 
strictly characterize therapeutic proteins to ensure reproducible glycosylation, 
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safety and efficacy as the absence, presence or type of glycan is known to dictate the 
efficacy of some therapeutic molecules [5].
Glycans are attached to certain asparagine residues (N-linked glycans) or serine/
threonine residues (O-linked glycans). N-linked glycosylation occurs at the Asn-
X-Ser/Thr/Cys (where X is not proline) consensus sequence on proteins that pass 
through the eukaryotic secretory pathway. There are three structural classes of 
N-glycan that share a common trimannosyl chitobiose core motif (Man3GlcNAc2) 
(Figure 1a). This core may be further variably decorated with mannose, fucose, 
galactose, sialic acid, N-acetylgalactosamine (GalNAc) and N-acetylglucosamine 
(GlcNAc). In contrast to N-glycans, O-glycans are appended to the hydroxyl oxygen 
of Ser or Thr residues with no strong consensus sequence defining a glycosite. 
There are eight structural classes of O-glycans that are defined by core di- or tri-
saccharides that occupy a glycosite (Figure 1b). Each of these cores can be further 
elaborated with other sugars yielding a large variety of possible O-glycan structures. 
Over 10% of secreted human proteins carry some form of O-glycan modification. A 
second form of O-glycosylation occurs on nuclear and cytoplasmic proteins, where 
a single β-linked GlcNAc is attached to Ser or Thr residues. β-O-GlcNAcylation is an 
essential, dynamic modification that is important in cell signaling and differentia-
tion [6]. Finally, chemical groups (e.g., sulfate, phosphate, acetate, methyl, etc.) 
may also occur at various positions on certain N- and O-glycan sugars [7].
Figure 1. 
Basic structures of N-glycans (a) and core structures of O-glycans (b). a, N-glycans can be categorized into 
three basic types: High mannose, Complex and Hybrid. The core structure (Man3GlcNAc2) of N-glycans is 
indicated by the orange triangle. A GlcNAc residue can attach to a β-mannose of the N-linked glycan core, 
resulting in a bisecting N-glycan (illustrated in Complex N-glycan). The reducing end GlcNAc (indicated by 
an arrow) of N-glycans can also be modified with a fucose (illustrated in Complex N-glycan). A N-glycan 
modifies a peptide via its reducing end GlcNAc attaching to Asparagine (N) within the peptide. b, eight core 
structures of O-glycans. O-glycan starts with a GalNAc (reducing end, indicated by an arrow), and further 
modifications can be added to the non-reducing end of the core structures. In O-glycopeptides, O-glycans are 
attached to the hydroxyl group of Serine (S) or Threonine (T) via the reducing end GalNAc.
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Protein glycosylation is remarkable in its structural complexity. This trait 
reflects the way in which glycans are synthesized and transferred to proteins. 
Glycans are assembled by complex biosynthetic pathways consisting of many 
different enzymes. Individual monosaccharides become linked together by glycos-
yltransferases that each have sugar and stereochemical specificity. For example, the 
elaborate mammalian 14 sugar N-glycan precursor consists of only three types of 
monosaccharides (Glc3Man9GlcNAc2), yet its assembly requires the coordinated 
action of 13 different glycosyltransferases. There are over 200 different glycos-
yltransferases that affect glycan structures in the mammalian glycome [8]. Gene 
expression of some of these enzymes varies by tissue, cell type, and epigenetic 
regulation resulting in significant structural variation of glycans. A glycoform is a 
single protein isoform having a defined glycan present at each glycosite. As such, 
proteins naturally exist as collections of glycoforms. Additionally, some protein 
isoforms periodically lack glycan occupancy at a potential glycosite. The complexity 
of these attributes of glycoproteins underscores the technical challenges associated 
with deconvoluting any given glycome.
Analysis of glycan structure has been performed several different ways. 
However, the most common approaches typically utilize one of two strategies: (i) 
analysis of glycans that have been released from glycoproteins or ii) bottom-up 
proteomics analysis of peptide/glycopeptide mixtures. Standard N-glycan profiling 
methods begin with liberation of N-glycans from a glycoprotein with the enzyme 
PNGase F. Typically, they are then labelled at their reducing ends with a fluoro-
phore, and separated via high/ultra-performance liquid chromatography (H/UPLC) 
or capillary electrophoresis (CE) with fluorescence detection and optional inline 
mass detection [9]. Glycan structures are assigned to observed peaks by comparing 
mobility and mass data to glycan reference databases [10]. Exoglycosidases with 
precise specificities can be used to further confirm structural assignments [11, 
12]. For O-glycans, no enzyme that releases a broad range of elaborated O-glycan 
structures has been identified. Chemical release of O-glycans via hydrazinolysis 
can be achieved, but this can damage some released glycans [13, 14]. In addition, 
released N- and O-glycans may be permethylated and analyzed directly by LC–MS/
MS or MALDI-MS [15]. Finally, for both N- and O-glycans, profiling of released 
glycans provides a catalog of the range of structures present in a sample, but it does 
not provide information regarding their point of attachment in a protein.
A more data-rich method of glycoprotein analysis uses bottom-up proteomics 
to analyze peptide/glycopeptide mixtures. In this approach, a glycoprotein is 
treated with a protease (e.g., trypsin) to generate a pool of peptides that are then 
analyzed by mass spectrometry (typically LC–MS/MS). Data are processed by 
computer algorithms with the help of protein and glycan mass reference databases 
(e.g., Byonic software and O-Pair Search) to generate a peptide map and identify 
appended glycans. Advantages of this method are that the same workflow can 
yield information about both N- and O-glycans (and other protein modifications), 
it identifies glycosites, it can determine both glycan occupancy and the range 
of glycan structures at each glycosite, and it can be quantitative. This approach 
(termed the ‘multi-attribute method’, MAM) is gaining traction in the pharmaceuti-
cal industry for monitoring the purity of biologic drugs and is expected to become 
the industry standard for final product characterization [16]. Despite its benefits, 
there are still technical challenges facing glycoproteomics analyses. For example, 
existing proteases (e.g., trypsin) used in proteomics often generate large peptides 
that may have multiple glycans (especially for O-glycans that tend to be clustered 
within proteins). These generated glycopeptides can be either too large to detect by 
MS or it can be difficult to assign glycosites on such peptides with high confidence. 
Therefore, better approaches are needed to generate glycopeptides. Additionally, 
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glycopeptides represent a small portion of a peptide mixture and often do not ionize 
well. New methods that address sample complexity through enrichment of specific 
glycopeptides are emerging.
The field has begun to address these issues through development of new reagents 
that aid in glycoproteomics. Novel proteases, including those that have specificity 
for O-glycans, have recently been characterized and validated in glycoproteomics 
workflows. Additionally, reagents and methods that permit selective enrichment of 
glycopeptides have been applied to reduce sample complexity. In this chapter, we 
review advances in glycopeptide generation and enrichment methods that are helping 
to improve glycopeptide analysis. Additionally, we present an example case study illus-
trating N-glycopeptide enrichment to address glycan heterogeneity in Wnt signaling.
2. A workflow for intact glycopeptide identification
A common strategy to determine protein glycosylation is shown in Figure 2. 
This process generally involves: (i) protease treatment of protein(s) to generate 
a peptide/glycopeptide mixture, (ii) glycopeptide enrichment, (iii) analysis of 
isolated glycopeptides by LC–MS/MS, (iv) computational analysis of mass data 
Figure 2. 
Basic workflow of intact glycopeptide identification.
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against proteome and glycan reference databases to yield both the peptide sequence 
and possible glycan structure for each peptide. Here we review technical challenges 
and recent advances for each step of glycopeptide analysis.
2.1 Peptide generation
To generate peptides for proteomics analyses, a protein sample is first digested with 
a protease. The specificity of the protease used can significantly impact the protein 
coverage obtained by the method. Trypsin, a protease that cleaves after lysine and 
arginine residues, has been the workhorse of the proteomics field for over two decades. 
Trypsin generally produces peptides of sufficient length to ionize efficiently in mass 
spectrometry. However, protein-specific challenges can occur with trypsin, especially 
with glycoproteins. For example, some proteins naturally lack lysine or arginine 
residues, have these residues disparately positioned, or have bulky glycans in close 
proximity that sterically hinder proteolysis. Each of these factors can produce larger 
peptides that typically do not ionize as well. As such, other proteases with cleavage 
specificities orthogonal to trypsin are often used to increase proteolytic peptide cover-
age (Table 1) [17]. For example, Figure 3 shows that α-Lytic Protease can be used 
alone or in combination with other proteases to yield increased sequence coverage.
A recent advance has been the use of O-glycan-specific proteases 
(O-endoproteases) for generating O-glycopeptides for analysis. These enzymes rec-
ognize and bind to mucin-type O-glycans, then cleave the peptide bond immediately 
N-terminal to the glycosylated serine or threonine. Used either alone or in series with 
other proteases like trypsin, glycopeptides are generated that have an O-glycan on 
their amino-terminal amino acid following cleavage. The first commercial enzyme 
of this class was the O-endoprotease from Akkermansia muciniphila (sold under the 
trade name OpeRATOR, Genovis AB, Sweden). This enzyme recognizes mammalian 
O-glycans but it is inhibited by the presence of terminal sialic acids. Accordingly, 
sialidase treatment is required for efficient performance which results in loss of 
glycan structural information. Recently, chemical modification of sialic acids has also 
been shown to improve OpeRATOR function [18]. In contrast, the O-glycoprotease 
newly available from New England Biolabs, is not inhibited by the presence of sialic 
acids and it also exhibits a broad specificity towards proteins with mammalian 
Protease Specificity
N-terminal cleavage AspN D (E)
LysN K
LysargiNase R, K
O-endoprotease S/T with O-glycan




chymotrypsin F, Y, L, W, M
Pepsin Y, F, W
α-Lytic Protease T, A, S, V (C, L)
Table 1. 
Proteases used in proteomics. Protease specificities are indicated using single letter codes for amino acid residues. 
Recognition sites that are cleaved at a lower rate are indicated by amino acids bracketed by parentheses.
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O-glycans. This enzyme recognizes O-glycans ranging in size from a minimal 
GalNAc-α-Ser/Thr structure to larger mucin-type O-glycans bearing branches and 
sialic acids. This specificity negates the need for sialidase treatment or chemical 
modification prior to O-glycopeptide generation. Resulting O-glycopeptides can be 
mapped to identify the protein of origin, the position of O-glycosites, and the range 
of O-glycan structures present at any given glycosite in a single experiment.
2.2 Glycopeptide enrichment methods
Glycopeptides are typically in low abundance compared to aglycosylated 
peptides in a peptide mixture. Additionally, it is well-established that ionization 
of glycopeptides is often weaker compared to aglycosylated peptides during MS 
analyses [19]. This results in aglycosylated peptide signals often dominating MS 
experiments. Therefore, enrichment of glycopeptides prior to sample analysis has 
been a growing trend to improve intact glycopeptide identification. Several enrich-
ment schemes that vary in their rationales have been described. These approaches 
range from general methods (enrichment of both N- and O-linked glycopeptides) 
to newer glycan class-specific approaches that selectively enrich for either N- or 
O-linked glycopeptides. Several approaches are summarized here.
2.2.1 Hydrophilic interaction liquid chromatography (HILIC)
HILIC has been widely used for glycopeptide enrichment. It is based on the 
interaction between the hydrophilic glycan moiety of a glycopeptide and the polar 
stationary phase in the non-polar mobile phase (typically acetonitrile). Many 
HILIC materials have been developed, however zwitterionic HILIC (ZIC-HILIC) 
enrichment is generally the most useful due to higher loading capacity and broader 
specificity. HILIC does not discriminate between O-linked and N-linked glycopep-
tides and hydrophilic non-glycosylated peptides may co-elute [20]. Thus, for more 
complete glycopeptide enrichment, HILIC may require a complementary chroma-
tography fractionation step [21].
2.2.2 Boronic acid
One method utilizes boronic acid presented on a solid support to react with 
cis-diol-containing saccharides or polyols to form five- or six-membered cyclic 
Figure 3. 
α-Lytic Protease can be used alone or in combination with other proteases to yield increased sequence coverage. 
Comparison of sequence coverage for three protein standards after parallel digestion using Trypsin (blue) 
or a-Lytic Protease (gold). The combined data set (grey) results in overlapping peptides and increased 
sequence coverage. (Reprinted by permission from New England Biolabs. https://www.neb.com/products/
p8113-a-lytic-protease#Product%20Information).
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esters. This property has been used to capture glycoproteins and glycopeptides [22]. 
Importantly, the covalent linkage is reversible at acidic pH which results in release 
of intact glycopeptides [20]. The interaction between boronic acid and sugars is 
relatively weak but newly characterized derivatives show promise for enrichment of 
low-abundance glycopeptides [19]. A final consideration is that boronic acid enrich-
ment does not discriminate between N- and O-linked glycopeptides.
2.2.3 Metal affinity chromatography
This method exploits the ability of negatively charged sialylated glycans to 
coordinate with titanium, zirconium or silver [23]. However, metal ion affinity 
chromatography is not strictly selective for sialylated glycans as negatively charged 
phosphopeptides or acidic peptides may compete for binding. Additionally, the 
method does not discriminate between N- and O-linked glycopeptides.
2.2.4 Hydrazide chemistry
Hydrazide chemistry has been widely used for glycosite characterization. Cis-
diols within glycans of glycopeptides may be oxidized to aldehydes (using periodate 
oxidation) forming a non-reversible covalent bond with hydrazide immobilized on 
a bead. PNGase F is then used to release the formerly N-linked glycosylated peptides 
to enable N-glycosite determination using MS [24]. Although more commonly used 
for N-glycosite determination, this chemistry can also be used to enrich glycopep-
tides having sialylated glycans. In this method, mild periodate treatment selectively 
oxidizes sialic acids thus enabling capture of sialyated N- and O-glycopeptides on 
hydrazide beads. The intact glycopeptides can then be selectively released by acid 
hydrolysis and analyzed by MS [25].
2.2.5 Enzyme-mediated O-glycopeptide enrichment
O-glycopeptides may be enriched using an enzyme-based workflow termed 
“EXoO” (extraction of O-linked glycopeptides) [26]. This method is enabled by 
the availability of O-endoproteases (described above). The workflow (Figure 4) 
involves digestion of a protein/biological sample with a standard protease such 
as trypsin to generate a peptide mixture. The peptides are conjugated to a solid 
support via the terminal NH2 group on each peptide (e.g., Aminolink™ beads, 
ThermoFisher). An O-endoprotease is used to specifically release O-glycopeptides 
from the beads. Efficiency of the method is dependent on the specificity of the 
O-endoprotease. This approach may be practiced with OpeRATOR (Genovis) 
following chemical modification of sialic acids [18] or with O-glycoprotease 
(New England Biolabs) which cleaves without pre-treatment to remove or modify 
sialic acids.
2.2.6 Native lectin-mediated glycopeptide enrichment
Lectins are non-catalytic proteins that bind to carbohydrates. Lectins have been 
used in a variety of glycan, glycoprotein and glycopeptide enrichment strategies. A 
common approach utilizes broad-specificity bead-immobilized lectins to capture a 
wide spectrum of glycopeptides. For example, the lectins Concanavalin A (ConA) 
and wheat germ agglutinin (WGA) bind to high mannose structures and GlcNAc or 
sialic acid residues, respectively. Each has been used to isolate N-glycopeptides from 
peptide mixtures [27]. However, WGA does not exclusively bind to N-glycopeptides 
as it also binds O-β-GlcNAc found on intracellular proteins [28]. Similar strategies 
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have been applied to O-glycopeptide enrichment. For example, the lectins Jacalin 
and Vicia villosa agglutinin (VVA) bind to O-linked Gal(β-1,3)GalNAc and α- or 
β- linked terminal N-acetylgalactosamine, respectively [29, 30].
Lectin-based enrichment strategies have some limitations due to their natural 
properties. First, most lectins bind their substrates rather weakly (Kd of ~10 mM to 
1 μM) [31]. Additionally, limitations in a lectin’s specificity can introduce bias into 
an enrichment scheme. Strategies employing multiple lectins (multi-lectin affinity 
chromatography, M-LAC) have successfully increased glycopeptide recovery and 
coverage but do not completely solve the problem of lectin specificity bias [32]. To 
improve the performance of lectins in glycopeptide enrichment strategies, today’s 
advanced capabilities for cloning and recombinant expression of lectins allows for 
mutagenesis and selection of lectins with improved binding properties.
2.2.7 Engineered lectins for N- and O-glycopeptide enrichment
The use of structure-guided protein engineering techniques has been used to 
create lectins with enhanced utility for glycopeptide enrichment. One area of inter-
est has been to engineer binding proteins that can stratify a peptide mixture into 
different classes of glycopeptides (e.g., N-glycopeptides or O-glycopeptides). Here 
we summarize recent progress in creating such reagents.
An ideal lectin for N-glycopeptide enrichment would bind to a structurally 
invariable portion of the N-glycan structure. A common trimannosyl chitobiose 
(Man3GlcNAc2) core glycan is a common feature of all N-glycans (Figure 1a). The 
human Fbs1 protein specifically recognizes this core motif [33, 34]. Fbs1 partici-
pates in glycoprotein quality control within the endoplasmic-reticulum-associated 
degradation (ERAD) system by binding to misfolded glycoproteins that have been 
retrotranslocated into the cytosol for degradation [35]. As part of the E3 ubiquitin 
complex, Fbs1 mediates ubiquitination and degradation of glycoproteins by the 
proteosome [33, 34]. Wild-type (wt) Fbs1 preferentially binds to high mannose 
N-glycans with sub-micromolar binding affinity (Kd of 0.1–0.2 μM) and only 
weakly binds to complex N-glycans having terminal sialic acids [36]. To adapt Fbs1 
for use as a universal N-glycan/N-glycopeptide binding reagent, Fbs1 variants with 
greater tolerance for the presence of sialic acids were engineered using a novel 
Figure 4. 
Basic workflow of O-glycopeptide enrichment by O-glycoprotease.
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plasmid display strategy where library variants were enriched for their ability to 
bind immobilized fetuin [37]. An Fbs1 variant (termed Fbs1-GYR) containing 
S155G, F173Y and E174R substitutions was identified that efficiently binds to both 
high mannose N-glycans and complex N-glycans (Figure 5). Fbs1-GYR is unhin-
dered by sialic acid and core fucose substitution, but does not bind to N-glycans 
bearing bisecting GlcNAc.
Fbs1-GYR is an efficient and substantially unbiased N-glycopeptide enrichment 
reagent. It enabled a deep characterization of the human serum N-glycoproteome 
[37] where Fbs1-GYR enrichment outperformed enrichment by the native lectin 
mixture of WGA, ConA and RCA120 (WCR). Fbs1-GYR enrichment enabled 
identification of 2.2-fold more N-glycopeptides: an average of 2,142 N-glycopeptide 
spectra with Fbs1-GYR whereas enrichment with the WCR lectin mixture yielded 
an average of 965 N-glycopeptide spectra when the same amount of sample was 
analyzed by MS [37]. Fbs1-GYR mediated enrichment may be performed by using 
the N-glyco FASP method [32] or by using Fbs1-GYR immobilized beads. In the 
latter case, Fbs1-GYR has been expressed as a fusion to a SNAP-tag which permits 
covalent conjugation to benzyl-guanine beads [37–39].
A lectin (termed ‘BGL’) from the North American Kurokawa mushroom 
(Boletopsis grisea) was recently shown to have a specificity suitable for enrichment 
of a broad range of O-glycan and O-glycopeptide structures [40]. BGL is a member 
of the fungal fruit body lectins (Pfam PF07367) that possess two ligand binding 
sites, as verified by x-ray crystallography [41, 42]. One site binds to N-glycans 
possessing outer-arm terminal GlcNAc and the other to O-glycans bearing the 
TF-antigen disaccharide Galβ1,3GalNAc [40]. Ganatra et al. used structure-guided 
mutagenesis to generate single ligand binding site BGL variants [40]. One mutant 
BGL protein (R103Y) lost the ability to bind N-glycans with a terminal GlcNAc but 
retained the ability to bind O-glycans bearing the Galβ1,3GalNAc epitope. Both the 
R103Y BGL variant and wt BGL were shown to specifically isolate O-glycopeptides 
from proteolyzed fetuin, a peptide mixture that contains N-, O- and aglycosyl-
ated peptides [40]. As the R103Y BGL variant does not bind to N-glycans, it shows 
promise as a selective O-glycan/O-glycopeptide enrichment reagent (Figure 6). It 
is plausible that BGL (R103Y) and Fbs1-GYR could be used in tandem to stratify 
glycopeptide mixtures into enriched pools of O- or N-glycopeptides, respectively.
Figure 5. 
Fbs1-GYR variant binding to a diverse set of N-glycopeptides is substantially unbiased. Sialylglycopeptide 
(SGP), an Fbs1 binding substrate, was fluorescently labeled with Tetramethylrhodamine (TMR) at the 
epsilon-amino group of lysine. For simplicity, TMR is only shown in N-glycopeptide structure 1. N-glycans of 
SGP-TMR (1) were trimmed with different combinations of exoglycosidases to produce asialo-SGP-TMR (2), 
SGP-TMR without sialic acids and galactose (3) and SGP-TMR without sialic acids, galactose and GlcNAc 
(4). The trimmed glycopeptides were then added to binding assays with wt Fbs1 or Fbs1-GYR beads in 50 mM 
ammonium acetate pH 7.5. The relative binding affinity to wt Fbs1 or Fbs1-GYR is reported as the recovery 
percentage (TMR fluorescence on beads/input TMR fluorescence). Results represent the mean ± s.e.m. of three 




2.3 LC-MS/MS and computer algorithms to search glycopeptides
2.3.1 LC-MS/MS
To identify intact glycopeptides, information of both the peptide backbone 
and the appended glycan is required. There are four major MS/MS fragmenta-
tion methods: collision induced dissociation (CID), electron-capture dissociation 
(ECD), electron transfer dissociation (ETD), and higher energy collisional dissocia-
tion (HCD). CID mainly fragments the peptide backbone, while ECD/ETD is more 
specific for glycan fragmentation. HCD can fragment both peptide backbone and 
glycan, and is widely used in intact glycopeptide MS/MS. A combination of differ-
ent fragmentation methods can improve intact glycopeptide identification.
One recent study reported analysis of more than 5,600 glycopeptides and 
1545 N-glycosites [43]. This report implemented a new type of tandem MS fragmenta-
tion: activated-ion electron transfer (AI-ETD). The analysis illustrated one of the first 
studies of glycoproteome profiling with AI-ETD on a quadrupole-Orbitrap-linear ion 
trap MS system (Orbitrap Fusion Lumos) [44]. Through specialized ion scanning 
routines, the authors acquired glycopeptide spectra with a higher-energy collision 
dissociation-product dependent-activated ion electron transfer dissociation (HCD-pd-
AI-ETD). This strategy borrows from an established approach in N-glycopeptide analy-
sis, HCD-product ion-triggered-ETD activation where abundant oxonium ions (m/z 
204.087, HexNAc) in HCD MS/MS initiate subsequent ETD of the selected precursors 
[45, 46]. The new method HCD-pd-AI-ETD showed a median of peptide backbone 
sequence coverage of 89% and a median 78% glycan sequence coverage [44]. These 
parameters were derived from informatics tools with multiple filtering steps post-
analysis. Overall, the filtering strategy aimed to attain no decoy peptide hits within the 
constraints of below 1% FDR estimations for both AI-ETD and HCD spectra.
2.3.2 Computer algorithms for intact glycopeptide identification
The complicated structure of intact glycopeptides makes the MS/MS spectra 
extremely complex. Therefore, special computer algorithms have been developed 
Figure 6. 
Enrichment of O-glycosylated peptides/peptiforms from Pronase digested bovine fetuin before or after 
enrichment with BGL or BGL variant R103Y. Sample 1 and 2 represent replicate samples that were each 
separately digested with Pronase and subjected to lectin enrichment. Blue bars represent the total number of 
peptides identified (unglycosylated peptides and O-glycopeptides). Yellow bars represent the number of unique 
O-glycopeptides/peptiforms identified in each sample. (This figure was originally published within Scientific 
Reports, Volume 11: Article number: 160 (2021)).
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to match the MS/MS spectra to both the peptide sequences and the attached glycan 
compositions. The algorithms include Byonic [47], GPQuest [48], pGlyco 2.0 
[49], and O-pair Search [50]. Amongst these programs, the Byonic search engine 
provides high sensitivity identification of glycopeptides and allows the use of 
customized databases for both glycans and proteins. Byonic software identifies 
glycopeptides to the level of glycan composition and peptide sequence, and it is 
suitable for both N-glycopeptide and O-glycopeptide searches. A newly published 
computer algorithm, called O-Pair Search, is specific for O-glycopeptide searches 
[50]. The authors claim that O-Pair Search can not only greatly reduce search times 
(up to more than 2,000-fold) compared to a Byonic search, but it can also generate 
more O-glycopeptide identifications.
3.  A case study: application of the Fbs1-GYR enrichment method to 
study N-glycan heterogeneity in Wnt signaling
The Wnt signaling pathway plays important roles in normal development and in 
cancer progression [51]. Several enzymes (such as DPAGT1) which are involved in 
N-glycan biogenesis are regulated by Wnt3a ligand stimulation [52, 53]. Therefore, 
an N-glycosylation study was performed to reveal potential biomarkers for the 
detection of Wnt-related cancers. We applied Fbs1-GYR enrichment technology 
to investigate whether protein N-glycosylation heterogeneity changes upon Wnt3a 
stimulation in mammalian cells.
Murine recombinant Wnt3a ligand and the Wnt Protein Stabilizer (AMS.
bWps) (ASMBio, Cambridge, MA) in combination were able to stimulate 
canonical Wnt signaling in HEK293 SuperTopFlash STF cells (ATCC CRL-3249) 
in serum free media. Controls cells (non-Wnt3a stimulated cells) were treated 
in the same manner but without addition of Wnt3a. A 103.6 ± 3.92 (n = 3) 
fold change in TopFlash reporter gene expression was observed after 24-hour 
stimulation with 50 ng/ml Wnt3a and 50 μg/ml of Stabilizer. Note that serum 
free media was necessary to prevent possible glycoprotein contamination from 
bovine serum.
Control cells or Wnt3a-stimulated cells were harvested, and total protein was 
digested with trypsin. N-glycopeptides were enriched with 50 μg Fbs1-GYR puri-
fied protein using the N-glyco-FASP method [32] from 200 μg of tryptic peptides 
prepared from either control cells or Wnt3a-stimulated cells. The enriched 
N-glycopeptide samples were subjected to LC–MS/MS analysis and N-glycopeptide 
searching by Byonic as described [37]. 1556 and 1233 N-glycopeptide spectrum 
matches (N-glyco PSM) were obtained from Wnt3a-stimulated cells and control 
cells, respectively. (The complete dataset is available upon request from the corre-
sponding author). The numbers of peptide spectrum matches (PSM) are suggestive 
of the relative abundance of the peptides [26]. Thus, the value of N-glyco PSM is 
used to evaluate and compare protein N-glycosylation in the Wnt3a-stimulated cells 
and the control cells. Using criteria of at least a two-fold change and a minimum 
10 PSM difference between Wnt3a-stimulated and control cells, 17 proteins were 
identified exhibiting significant changes in N-glycosylation (Table 2). Among 
them, N-glycosylation of 11 proteins (MPRI, AN32B, PON2, SAP, NOMO3, TMED4, 
FKBP9, ATRN1, LMNB2, ZMAT4, and BASI) showed a significant increase upon 
Wnt3a stimulation, while N-glycosylation of 6 proteins (MA2B1, PLOD1, MPRD, 
MOMO1, HEAT1, and ABCAD) was significantly reduced with Wnt3a stimulation. 
MPRI (Cation-independent M6P receptor) and MPRD (Cation-dependent M6P 
receptor) are both mannose-6-phosphate (M6P) receptors. However, they display 
an opposite response to Wnt3a stimulation with regard to N-glycosylation (Table 2,  
Table 3 highlighted within the dark blue box). The detected N-glycosylation of 
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|Uniprot ID| N-glycoprotein identity Spectral Counts ratio
Wnt3a control Wnt3a/Control
1 |P11717|MPRI_HUMAN Cation-independent 
mannose-6-phosphate receptor OS=Homo 
sapiens GN=IGF2R PE = 1 SV = 3
35 3 11.7
2 |Q92688|AN32B_HUMAN Acidic leucine-rich 
nuclear phosphoprotein 32 family member B 
OS=Homo sapiens GN = ANP32B PE = 1 SV = 1
20 6 3.3
3 |Q15165|PON2_HUMAN Serum paraoxonase/
arylesterase 2 OS=Homo sapiens GN=PON2  
PE = 1 SV = 3
19 9 2.1
4 |O00754|MA2B1_HUMAN Lysosomal alpha-
mannosidase OS=Homo sapiens GN = MAN2B1 
PE = 1 SV = 3
3 15 0.2
5 |Q02809|PLOD1_HUMAN Procollagen-lysine,2-
oxoglutarate 5-dioxygenase 1 OS=Homo sapiens 
GN=PLOD1 PE = 1 SV = 2
4 17 0.2
6 |P20645|MPRD_HUMAN Cation-dependent 
mannose-6-phosphate receptor OS=Homo 
sapiens GN = M6PR PE = 1 SV = 1
7 22 0.3
7 |P07602|SAP_HUMAN Prosaposin OS=Homo 
sapiens GN=PSAP PE = 1 SV = 2
63
8 |P69849|NOMO3_HUMAN Nodal modulator 3 
OS=Homo sapiens GN=NOMO3 PE = 2 SV = 2
18
9 |Q7Z7H5|TMED4_HUMAN Transmembrane 
emp24 domain-containing protein 4 OS=Homo 
sapiens GN = TMED4 PE = 1 SV = 1
17
10 |O95302–3|FKBP9_HUMAN Isoform 3 of 
Peptidyl-prolyl cis-trans isomerase FKBP9 
OS=Homo sapiens GN=FKBP9
13
11 |Q5VV63|ATRN1_HUMAN Attractin-like protein 
1 OS=Homo sapiens GN = ATRNL1 PE = 2 SV = 2
11
12 |Q03252|LMNB2_HUMAN Lamin-B2 OS=Homo 
sapiens GN = LMNB2 PE = 1 SV = 3
10
13 |Q9H898|ZMAT4_HUMAN Zinc finger matrin-
type protein 4 OS=Homo sapiens GN = ZMAT4 
PE = 2 SV = 1
10
14 |P35613|BASI_HUMAN Basigin OS=Homo 
sapiens GN=BSG PE = 1 SV = 2
10
15 |Q15155|NOMO1_HUMAN Nodal modulator 1 
OS=Homo sapiens GN=NOMO1 PE = 1 SV = 5
26
16 |Q9H583|HEAT1_HUMAN HEAT repeat-
containing protein 1 OS=Homo sapiens 
GN=HEATR1 PE = 1 SV = 3
17
17 |Q86UQ4|ABCAD_HUMAN ATP-binding 
cassette sub-family A member 13 OS=Homo 
sapiens GN = ABCA13 PE = 2 SV = 3
14
Table 2. 
List of 17 proteins with significant differences in overall N-glycosylation upon Wnt3a stimulation. 
N-glycosylation is evaluated by spectral counting label-free quantification. The scoring criteria was a minimum 
of 10 PSM difference and a fold change minimum of 2 between Wnt3a-stimulated cells and the control cells.
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Table 3. 
Comparison of detected N-glycosylation in MA2B1, MPRI, MPRD, and HYOU1 in Wnt3a-stimulated cells 
and the control cells. The light green rows indicate N-glycoprotein identity. Beneath the protein identity row, 
N-glycosites are listed in light blue. Beneath each N-glycosite, the respective N-glycan composition is listed. 
N@ indicates the asparagine with N-glycan modification. PSM numbers of individual N-glycosylation 
modifications are listed in columns on the right side.
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MPRI increases 11.7 fold, while N-glycosylation of MPRD decreases approximately 
3-fold after Wnt3a stimulation. The observed N-glycosylation changes may be due to 
the changes of protein expression level, which deserves further investigation.
The N-glyco PSM of lysosomal alpha-mannosidase (MA2B1(O00754)), is greatly 
reduced (5-fold) with Wnt3a stimulation. Interestingly, the N-glycosylation change 
is mainly due to differential glycosylation of N133 of MA2B1(O00754). Table 3 
shows 11 PSM with a fucosylated N-glycan (HexNAc(2)Hex(3)Fuc(1)) were found 
at position N133 attached to this mannosidase in control cells, but only one PSM 
was detected in the Wnt3a-stimulated cells (highlighted in the red box). Thus, we 
speculate that reduced N-glycosylation may affect stability of this mannosidase 
in the lysosome resulting in altered N-glycosylation of substrate proteins. The 
extent of N-glycosylation of some enzymes did not differ significantly between 
Wnt3a-stimulated cells and the control cells. However, modification of a specific 
N-glycosite did differ significantly. For example, there was no significant fold 
change with regard to the total numbers of N-glyco PSM of HYOU1, Hypoxia up-
regulated protein 1, which were 71 and 119 in control and Wnt3a-stimulated cells, 
respectively (Table 3). However, a 3-fold increase in N-glycosylation at position 
N931 of HYOU1 was found upon Wnt3a stimulation (57 PSM in Wnt3a-stimulated 
cells vs. 19 PSM in control cells, Table 3, highlighted in the green box). Overall, this 
study demonstrates that the Fbs1-GYR enrichment method allows for the examina-
tion of glycosite heterogeneity of individual cellular proteins, and this study has 
revealed candidate biomarkers for Wnt-related cancers.
4. Conclusion
Due to the inherent complexity of protein glycosylation, better reagents and 
workflows are required in order to thoroughly and accurately characterize the 
glycosylation profile within a sample of interest. Intact glycopeptide identification 
(glycosite and glycan composition) has emerged as a more effective means to study 
heterogeneity, to investigate disease biomarkers and to characterize therapeutic 
proteins. Fortunately, several notable advances have arisen in the last few years. 
These advances include chemical enrichment strategies, engineered lectins with 
improved specificity, a greater selection of site-specific proteases, more sophis-
ticated mass spectrometry methods/instruments and finally the development of 
computer algorithms designed for deconvolution of glycopeptide fragmentation 
spectra. Although challenges remain, these advances have certainly simplified the 
study of protein glycosylation.
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